These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23055795)

  • 1. Penetrance rate estimation in autosomal dominant conditions.
    Otto PA; Horimoto AR
    Genet Mol Biol; 2012 Jul; 35(3):583-8. PubMed ID: 23055795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calculating variant penetrance from family history of disease and average family size in population-scale data.
    Spargo TP; Opie-Martin S; Bowles H; Lewis CM; Iacoangeli A; Al-Chalabi A
    Genome Med; 2022 Dec; 14(1):141. PubMed ID: 36522764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygosity probabilities for normal relatives of isolated cases affected by incompletely penetrant conditions and the calculation of recurrence risks for their offspring. I. Autosomal dominant genes.
    Otto PA; Maestrelli SR
    Am J Med Genet; 2000 Nov; 95(1):43-8. PubMed ID: 11074493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating the penetrance of pathogenic gene variants in families with missing pedigree information.
    Jonker MA; Rijken JA; Hes FJ; Putter H; Hensen EF
    Stat Methods Med Res; 2019; 28(10-11):2924-2936. PubMed ID: 30073909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PENCALC: A program for penetrance estimation in autosomal dominant diseases.
    Horimoto AR; Onodera MT; Otto PA
    Genet Mol Biol; 2010 Jul; 33(3):455-9. PubMed ID: 21637415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nonparametric method for penetrance function estimation.
    Alarcon F; Bonaïti-Pellié C; Harari-Kermadec H
    Genet Epidemiol; 2009 Jan; 33(1):38-44. PubMed ID: 18618769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter Cohorts.
    Shin SJ; Dodd-Eaton EB; Peng G; Bojadzieva J; Chen J; Amos CI; Frone MN; Khincha PP; Mai PL; Savage SA; Ballinger ML; Thomas DM; Yuan Y; Strong LC; Wang W
    Cancer Res; 2020 Jan; 80(2):354-360. PubMed ID: 31719101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Likelihood formulation of parent-of-origin effects on segregation analysis, including ascertainment.
    Haghighi F; Hodge SE
    Am J Hum Genet; 2002 Jan; 70(1):142-56. PubMed ID: 11741195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal designs for estimating penetrance of rare mutations of a disease-susceptibility gene.
    Gong G; Whittemore AS
    Genet Epidemiol; 2003 Apr; 24(3):173-80. PubMed ID: 12652521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features.
    Rosanoff MJ; Ottman R
    Neurology; 2008 Aug; 71(8):567-71. PubMed ID: 18711109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MLEP: an R package for exploring the maximum likelihood estimates of penetrance parameters.
    Sugaya Y
    BMC Res Notes; 2012 Aug; 5():465. PubMed ID: 22929166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.
    Carayol J; Bonaïti-Pellié C
    Genet Epidemiol; 2004 Sep; 27(2):109-17. PubMed ID: 15305327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.
    Shin SJ; Dodd-Eaton EB; Gao F; Bojadzieva J; Chen J; Kong X; Amos CI; Ning J; Strong LC; Wang W
    Cancer Res; 2020 Jan; 80(2):347-353. PubMed ID: 31719099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.
    Bonaïti B; Bonadona V; Perdry H; Andrieu N; Bonaïti-Pellié C
    Eur J Hum Genet; 2011 Feb; 19(2):173-9. PubMed ID: 20924409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bayesian estimation of a semiparametric recurrent event model with applications to the penetrance estimation of multiple primary cancers in Li-Fraumeni syndrome.
    Shin SJ; Li J; Ning J; Bojadzieva J; Strong LC; Wang W
    Biostatistics; 2020 Jul; 21(3):467-482. PubMed ID: 30445420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations.
    Michelucci R; Pasini E; Malacrida S; Striano P; Bonaventura CD; Pulitano P; Bisulli F; Egeo G; Santulli L; Sofia V; Gambardella A; Elia M; de Falco A; Neve Al; Banfi P; Coppola G; Avoni P; Binelli S; Boniver C; Pisano T; Marchini M; Dazzo E; Fanciulli M; Bartolini Y; Riguzzi P; Volpi L; de Falco FA; Giallonardo AT; Mecarelli O; Striano S; Tinuper P; Nobile C
    Epilepsia; 2013 Jul; 54(7):1288-97. PubMed ID: 23621105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
    Antoniou AC; Durocher F; Smith P; Simard J; Easton DF;
    Breast Cancer Res; 2006; 8(1):R3. PubMed ID: 16417652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penetrance of schizophrenia-related disorders in multiplex families after correction for ascertainment.
    Levinson DF; Mowry BJ; Sharpe L; Endicott J
    Genet Epidemiol; 1996; 13(1):11-21. PubMed ID: 8647375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families.
    Saporta MA; Zaros C; Cruz MW; André C; Misrahi M; Bonaïti-Pellié C; Planté-Bordeneuve V
    Eur J Neurol; 2009 Mar; 16(3):337-41. PubMed ID: 19364362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of ascertainment on penetrance estimates for rare variants: Implications for establishing pathogenicity and for genetic counselling.
    Paterson AD; Seok SC; Vieland VJ
    PLoS One; 2023; 18(9):e0290336. PubMed ID: 37733810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.